You are here

IQ MEDICAL IMAGING LLC

Company Information
Address
116 DOUGLAS RD
BELMONT, MA 02478-3915
United States



Information

UEI: S1NEHNL85QA7

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. MDCT Quantification of hepatic tumor viability for assessment of cancer therapy

    Amount: $240,583.00

    Project Summary / Abstract Tumor imaging quantification is critical for cancer diagnosis, staging, and treatment evaluation, and multi-detector CT (MDCT) is the clinical imaging modality commonly used ...

    SBIRPhase II2021Department of Health and Human Services National Institutes of Health
  2. MDCT Quantification of hepatic tumor viability for assessment of cancer therapy

    Amount: $1,442,684.00

    Project SummaryAbstract Tumor imaging quantification is critical for diagnosisstagingand treatment evaluationand multi detector CTMDCTis the clinical imaging modality commonly used for patients diagno ...

    STTRPhase II2018Department of Health and Human Services National Institutes of Health
  3. Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses

    Amount: $1,459,820.00

    Project SummaryAbstract The neurofibromatosesNFsincluding NFNFand schwannomatosisare a group of autosomal dominant neurogenetic disorders characterized by a predisposition in virtuallyof patients to d ...

    STTRPhase II2018Department of Health and Human Services National Institutes of Health
  4. Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses

    Amount: $225,000.00

    DESCRIPTION provided by applicant The neurofibromatoses NFs including NF NF and schwannomatosis are a group of autosomal dominant neurogenetic disorders characterized by a predisposition in ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  5. MDCT Quantification of hepatic tumor viability for assessment of cancer therapy

    Amount: $222,795.00

    DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy (more than 80%) and the third most common cause of death from cancer worldwide. Contra ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government